With this Master's Degree you will be able to improve your knowledge of the latest diagnostic and treatment techniques for the different types of Skin Cancer "

In recent years, Skin Cancer has experienced a worrying increase in its incidence. This is due to prolonged exposure to ultraviolet radiation from the sun, environmental and genetic factors. In this aspect, the early detection of Skin Cancer is crucial for a successful treatment and to improve the survival rates of patients. For this reason, it is essential that the specialist is constantly informed about this disease, in order to introduce the most wellknown advances in its therapeutics and under the maximum scientific rigor. 

For this reason, TECH has created this degree that will provide a high-level education to the health professional in the latest diagnostic advances and treatment techniques used in Skin Cancer . During a period of 12 months of study, the graduate will deepen in the different types of surgery used to address this disease, such as curettage and electrocoagulation.  

Students will also learn about the various techniques for the evaluation and detection of cancer, such as sentinel lymph node biopsy and photodynamic therapy. In addition, thanks to the quality multimedia content, students will delve into the topical treatments used for cutaneous cancer such as 5-fluorouracil and imiquimod. 

Consequently, this Master's Degree gives professionals the opportunity to access a quality, flexible program that allows them to combine it with their daily activities by not having to attend classroom classes, nor to have classes with restricted schedules. In addition, this modality, combined with the Relearningmethod, will allow the specialist to review the most important concepts in a more efficient way and without requiring extensive hours of study.

You will delve into the molecular basis of melanoma, covering the genetic modifications and signaling pathways involved in its progression"

This Master's Degree in Skin Cancer contains the most complete and up-to-date scientific program on the market. The most important features include: 

• The development of case studies presented by experts in Dermatology, Oncology and Plastic and Reconstructive Surgery
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• Practical exercises where self-assessment can be used to improve learning
• Its special emphasis on innovative methodologies  
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments 
• Content that is accessible from any fixed or portable device with an Internet connection

You will incorporate in your medical practice the most recent surgical techniques and photodynamic therapies for the approach of Basal Cell Carcinoma"

The program’s teaching staff includes professionals from sector who contribute their work experience to this educational program, as well as renowned specialists from leading societies and prestigious universities.  

Its multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide an immersion education programmed to learn in real situations.  

The design of this program focuses on Problem Based Learning, through which the students will try to solve the different situations of professional practice that will be presented to them throughout the academic course. For this purpose, the student will be assisted by an innovative interactive video system created by renowned experts.

You will gain additional skills in the evaluation of Merkel cell carcinoma lesions based on the latest scientific evidence"

With this degree you will delve into the mechanisms of squamous cell carcinoma and emerging therapeutic techniques"

The syllabus of this program covers a wide range of pertinent concepts related to Skin Cancer . This way, the medical specialist will keep up to date with the latest advances in diagnostic techniques, treatment and evaluation of the main pathologies derived from Skin Cancer. It will also delve into up-to-date techniques of analysis and surgery. In addition, the contents will be available to physicians in various multimedia formats such as video summaries and simulations of real cases. In addition, medical professionals will be able to access this material 100% online, without having to adhere to specific schedules.

You will enjoy a personalized study plan, developed with the most effective pedagogical approach, the Relearning method"

Module 1. Skin Cancer 

1.1. Advanced skin biology 

1.1.1. Skin Anatomy 
1.1.2. Functions of the Skin 
1.1.3. Structural characteristics of the skin 
1.1.4. Epidermis, Dermis, Hypodermis, Skin appendages 

1.2. Genetics of skin cancer 

1.2.1. Analysis of the genetics of skin cancer 
1.2.2. Heredity and risk 
1.2.3. Genes associated with skin cancer 
1.2.4. Syndromes associated with Skin Cancer 
1.2.5. Other genes with possible susceptibility in Melanoma 

1.3. Risk Factors 

1.3.1. Description of risk factors 
1.3.2. Skin phototypes 
1.3.3. Radiation exposure 
1.3.4. Exposure to certain chemicals 

1.4. Prevention of skin cancer 

1.4.1. Evaluation of skin cancer prevention 
1.4.2. Photo protection 
1.4.3. Sunscreens 
1.4.4. Other Measures 

1.5. Classification 

1.5.1. Non-Melanoma Skin Cancer 
1.5.2. Basal Cell Carcinoma 
1.5.3. Squamous cell carcinoma of the skin 
1.5.4. Melanoma 

1.6. Clinical signs and symptoms 

1.6.1. Signs and symptoms of basal cell carcinoma
1.6.2. Signs and symptoms of squamous cell carcinoma 
1.6.3. Signs and symptoms of Melanoma 
1.6.4. Signs and symptoms of less common types of skin cancer

1.7. Diagnostic tests in skin cancer 

1.7.1. Analysis of diagnostic tests in Skin Cancer 
1.7.2. Confocal reflectance microscopy
1.7.3. Biopsies 
1.7.4. Skin ultrasound 

1.8. Dermatoscopy 

1.8.1. Analysis of dermoscopy of hyperpigmented lesions
1.8.2. Description of the dermoscopic parameters used in the 3-point rule and the BLINCK algorithm
1.8.3. Dermatoscopic diagnostic procedure 
1.8.4. Three-point rule 

1.9. Margin study method 

1.9.1. Lateral and deep resection margins considerations in skin tumor excision specimens 
1.9.2. Evaluation of the surgical margins of basal cell carcinoma  
1.9.3. Evaluation of Melanoma margins 

1.10. Molecular Biology Techniques 

1.10.1. Evaluation of molecular biology techniques 
1.10.2. Molecular biology in dermatological diagnostics 
1.10.3. Obtaining DNA/RNA 
1.10.4. Nucleic acid hybridization techniques  

Module 2. Melanoma 

2.1. Molecular Targets in Melanoma 

2.1.1. Description of Molecular Targets in Melanoma 
2.1.2. Molecular targets that drive the mechanisms of invasion and metastasis: anti adhesion molecule therapy
2.1.3. Therapeutic targets localized in the tumor cells themselves
2.1.4. Therapeutic targets localized in structures outside the neoplastic cells  

2.2. Biologic prognostic markers in melanoma

2.2.1. Hsp90 
2.2.2. RGS1 
2.2.3. Osteopontin 
2.2.4. HER3 

2.3. Classification of Melanoma 

2.3.1. Melanoma of superficial extension 
2.3.2. Nodular melanoma 
2.3.3. Acral lentiginous melanoma 
2.3.4. Mucosal melanoma 

2.4. Molecular classification of melanoma 

2.4.1. Molecular Analysis of melanoma 
2.4.2. Melanomas on sun-damaged skin 
2.4.3. Melanomas on skin without sun damage 

2.5. The ABCDE of Melanoma 

2.5.1. Asymmetries 
2.5.2. Border 
2.5.3. Color 
2.5.4. Diameter 
2.5.5. Evolution 

2.6. Clinical Stages of Melanoma 

2.6.1. Melanoma staging system 
2.6.2. Stage 0 Melanoma (Melanoma in situ) 
2.6.3. Clinical Stage I and II 
2.6.4. Clinical Stage III - Clinical Stage IV 

2.7. Sentinel lymph node in Melanoma

2.7.1. Sentinel lymph node assessment in Melanoma 
2.7.2. Lymphatic mapping 
2.7.3. Biopsy of Sentinel Lymph Node 

2.8. Surgical Treatment of Melanoma 

2.8.1. Extensive local excision 
2.8.2. Mohs Surgery 
2.8.3. Lymphadenectomy 

2.9. Melanoma Reconstruction 

2.9.1. Skin graft  
2.9.2. Local flap  
2.9.3. Free flap 

2.10. Adjuvant Treatment of Melanoma 

2.10.1. Chemotherapy 
2.10.2. Radiotherapy 
2.10.3. Immunotherapy 
2.10.4. Targeted therapy 

Module 3. Basal Cell Carcinoma 

3.1. Basal Cell Carcinoma Analysis 

3.1.1. Basal Cell Carcinoma Assessments 
3.1.2. Basal Cell Carcinoma Epidemiology 
3.1.3. Risk factors in Basal Cell Carcinoma 
3.1.4. Basal Cell Carcinoma Pathogenesis  

3.2. Clinical variants 

3.2.1. Nodular 
3.2.2. Morpheiform  
3.2.3. Superficial 
3.2.4. Fibroepithelioma 

3.3. Diagnosis 

3.3.1. Clinical Symptoms 
3.3.2. Dermatoscopy 
3.3.3. Optical Coherence Tomography 
3.3.4. Confocal reflectance microscopy 

3.4. Clinical stages  

3.4.1. Staging systemClinical Status  
3.4.2. Stage 0  
3.4.3. Clinical Stage I and II 
3.4.4. Clinical Stage III - Clinical Stage IV 

3.5. Sentinel lymph node 

3.5.1. Sentinel node analysis 
3.5.2. Lymphatic mapping 
3.5.3. Biopsy of Sentinel Lymph Node 

3.6. Surgical Management  

3.6.1. Extensive local excision 
3.6.2. Mohs Surgery 
3.6.3. Lymphadenectomy 

3.7. Reconstruction 

3.7.1. Skin graft 
3.7.2. Local flap 
3.7.3. Free flap 

3.8. Adjuvant Treatment  

3.8.1. Chemotherapy 
3.8.2. Radiotherapy 
3.8.3. Photodynamic therapy (PDT) 
3.8.4. Hedgehog pathway inhibitors 

3.9. Prognosis  

3.9.1. Stage 0  
3.9.2. Clinical Stage I and II 
3.9.3. Clinical Stage III  
3.9.4. Clinical Stage IV 

3.10. Follow-up and recommendations 

3.10.1. Initial stage: First year 
3.10.2. Follow up: Second year 
3.10.3. Long term 
3.10.4. Recommendations 

Module 4. Merkel Cells Carcinoma

4.1. Analysis of Merkel cell carcinoma  

4.1.1. Evaluation of Merkel cell carcinoma  
4.1.2. Evolution of Merkel Cell Carcinoma  
4.1.3. Epidemiology of Merkel cell carcinoma  
4.1.4. Etiopathogenesis and population at risk for Merkel cell carcinoma  

4.2. Diagnosis  

4.2.1. Clinical Symptoms 
4.2.2. Evolution 
4.2.3. Immunohistochemistry
4.2.4. Cytogenetic and molecular study 

4.3. CT and Biopsy  

4.3.1. CAT  
4.3.2. PET-CAT  
4.3.3. Large needle biopsy  
4.3.4. Fine needle aspiration biopsy 

4.4. Staging  

4.4.1. Stage IA  
4.4.2. Stage IB  
4.4.3. Stage II  
4.4.4. Stage III 

4.5. Sentinel lymph node  

4.5.1. Sentinel node analysis  
4.5.2. Lymphatic mapping  
4.5.3. Biopsy of Sentinel Lymph Node 

4.6. Surgical Management  

4.6.1. Extensive local excision  
4.6.2. Mohs Surgery  
4.6.3. Lymphadenectomy 

4.7. Reconstruction  

4.7.1. Skin graft  
4.7.2. Local flap  
4.7.3. Free flap 

4.8. Adjuvant Treatment  

4.8.1. Chemotherapy  
4.8.2. Radiotherapy  
4.8.3. Immunotherapy  
4.8.4. Targeted therapy 

4.9. Follow-up and recommendations  

4.9.1. Initial stage: First year  
4.9.2. Follow up: Second year  
4.9.3. Long term  
4.9.4. Recommendations 

4.10. AEDV Clinical Practice Guideline on Merkel Cell Carcinoma  

4.10.1. Analysis of the guideline  
4.10.2. Evaluation of the guideline  
4.10.3. Use of the guide  
4.10.4. Method used to prepare the document 

Module 5. Squamous cell carcinoma 

5.1. Analysis of squamous cell carcinoma  

5.1.1. Evaluation of Epidermoid Carcinoma  
5.1.2. Epidemiology of carcinoma epidermoidis  
5.1.3. Risk factors for squamous cell carcinoma  
5.1.4. Pathogenesis of Squamous Cell Carcinoma 

5.2. Clinical variants  

5.2.1. Acantholytic Squamous Carcinoma  
5.2.2. Spindle cell squamous carcinomas 
5.2.3. Verrucous squamous carcinoma  
5.2.4. Squamous clear cell carcinoma 

5.3. Diagnosis  

5.3.1. Clinical Symptoms  
5.3.2. Dermatoscopy  
5.3.3. Optical Coherence Tomography  
5.3.4. Confocal reflectance microscopy 

5.4. Prognostic factors in high-risk cutaneous squamous cell carcinoma

5.4.1. Size  
5.4.2. Depth  
5.4.3. Perineural invasion  
5.4.4. Lymphovascular invasion 

5.5. Other prognostic factors  

5.5.1. Histological type  
5.5.2. Immunosuppression  
5.5.3. VPH Infection  
5.5.4. High risk areas and drainage areas 

5.6. Clinical stages  

5.6.1. Staging system Clinical Status  
5.6.2. Stage 0  
5.6.3. Clinical Stage I and II  
5.6.4. Clinical Stage III - Clinical Stage IV 

5.7. Sentinel lymph node  

5.7.1. Sentinel node analysis  
5.7.2. Lymphatic mapping  
5.7.3. Biopsy of Sentinel Lymph Node 

5.8. Surgical Management  

5.8.1. Extensive local excision  
5.8.2. Mohs Surgery  
5.8.3. Lymphadenectomy 

5.9. Adjuvant Treatment  

5.9.1. Chemotherapy  
5.9.2. Radiotherapy  
5.9.3. Photodynamic therapy (PDT) 

5.10. Follow-up and recommendations  

5.10.1. Initial stage: First year  
5.10.2. Follow up: Second year  
5.10.3. Long term  
5.10.4. Recommendations 

Module 6. Other Skin Neoplasms 

6.1. Evaluation of other Skin Neoplasms  

6.1.1. Classification of other Skin Neoplasms  
6.1.2. Staging of other Skin Neoplasms  
6.1.3. Diagnosis of other Skin Neoplasms

6.2. Oral cavity squamous cell carcinoma  

6.2.1. Analysis of squamous cell carcinoma of the oral cavity  
6.2.2. Histopathology of oral cavity squamous cell carcinoma  
6.2.3. Diagnosis of oral cavity squamous cell carcinoma 
6.2.4. Treatment of squamous cell carcinoma of the oral cavity  

6.3. Penile squamous cell carcinoma  

6.3.1. Evaluation of penile squamous cell carcinoma  
6.3.2. Histopathology of penile squamous cell carcinoma  
6.3.3. Diagnosis of penile squamous cell carcinoma  
6.3.4. Treatment of penile squamous cell carcinoma  

6.4. Anal squamous carcinoma  

6.4.1. Analysis of anal squamous cell carcinoma  
6.4.2. Histopathology of anal squamous cell carcinoma  
6.4.3. Diagnosis of anal squamous cell carcinoma  
6.4.4. Treatment of anal squamous cell carcinoma  

6.5. Kaposi's Sarcoma  

6.5.1. Evaluation of Kaposi's sarcoma  
6.5.2. Histopathology of Kaposi's Sarcoma   
6.5.3. Diagnosis of Kaposi's sarcoma  
6.5.4. Treatment of Kaposi's sarcoma  

6.6. Leukoplakia

6.6.1. Analysis of Leukoplakia  
6.6.2. Histopathology of Leukoplakia  
6.6.3. Diagnosis of Leukoplakia  
6.6.4. Treatment of leukoplakia  

6.7. Keratoacanthomas  

6.7.1. Evaluation of Keratoacanthomas Histopathology of keratoacanthomas  
6.7.3. Diagnosis of Keratoacanthomas  
6.7.4. Treatment of keratoacanthomas  

6.8. Invasive Paget’s Disease  

6.8.1. Analysis of extramammary Paget's disease  
6.8.2. Histopathology of extramammary Paget's disease  
6.8.3. Diagnosis of extramammary Paget disease  
6.8.4. Treatment of extramammary Paget disease  

6.9. Malignant subcutaneous or soft-tissue tumors (sarcomas)  

6.9.1. Dermatofibrosarcoma  
6.9.2. Leiomyosarcomas  
6.9.3. Rhabdomyosarcoma  
6.9.4. Liposarcomas  

6.10. Epidermal lesions  

6.10.1. Actinic Keratosis
6.10.2. Bowen's Disease
6.10.3. Spitzoid lesions 

Module 7. Skin Cancer Treatments

7.1. Curettage and electrodesiccation  

7.1.1. Analysis of curettage and electrodesiccation  
7.1.2. Types of cancer using curettage and electrodesiccation  
7.1.3. Uses of curettage and electrodesiccation to treat cancer  
7.1.4. Benefits of curettage and electrodesiccation 

7.2. Curettage and electrocoagulation  

7.2.1. Analysis of curettage and electrocoagulation  
7.2.2. Types of cancer where curettage and electrocoagulation are used
7.2.3. Uses of curettage and electrocoagulation to treat cancer
7.2.4. Benefits of curettage and electrocoagulation 

7.3. Cryotherapy Skin cancer  

7.3.1. Analysis of cryotherapy  
7.3.2. Types of cancer where cryotherapy is used
7.3.3. Use of cryotherapy to treat cancer
7.3.4. Benefits of cryotherapy  

7.4. Wide excision  

7.4.1. Analysis of wide excision  
7.4.2. Types of Cancer where wide excision is used  
7.4.3. Use of wide excision to treat Cancer  
7.4.4. Benefits of wide excision  

7.5. Mohs micrographic surgery  

7.5.1. Evaluation of Mohs micrographic surgery 
7.5.2. Indications for Mohs surgery 
7.5.3. Variants of the technique  
7.5.4. Mohs fixed in kerosene: «slow-Mohs»  

7.6. Biopsy of Sentinel Lymph Node  

7.6.1. Sentinel lymph node biopsy analysis  
7.6.2. Mechanism of lymphatic metastasis  
7.6.3. Sentinel lymph node technique  
7.6.4. Detection  

7.7. Reconstructive Surgery  

7.7.1. Evaluation of reconstructive surgery  
7.7.2. Mechanism of reconstructive surgery  
7.7.3. Reconstructive surgery technique  
7.7.4. Benefits of reconstructive surgery  

7.8. Photodynamic Therapy  

7.8.1. Evaluation of photodynamic therapy  
7.8.2. Types of cancer where photodynamic therapy is used
7.8.3. How Photodynamic Therapy is used to treat Cancer  
7.8.4. Benefits of Photodynamic Therapy

7.9. Topical treatments in cancer  

7.9.1. 5-Fluorouracil (5-FU)  
7.9.2. Diclofenac (Solaraze)  
7.9.3. Ingenol mebutate (Picato)  
7.9.4. Imiquimod (Zyclara)  

7.10. Lymphadenectomy   

7.10.1. What is Lymphadenectomy  
7.10.2. Indications  
7.10.3. Benefits of Lymphadenectomy  
7.10.4. Disadvantages of Lymphadenectomy 

Module 8. Cutaneous Lymphomas 

8.1. Skin Lymphoma Analysis  

8.1.1. Skin Lymphoma Evaluation  
8.1.2. Classification of skin lymphomas  
8.1.3. Diagnosis of skin lymphomas  
8.1.4. Treatment of skin lymphomas  

8.2. Lymphomatoid Papulosis  

8.2.1. Clinic in lymphomatoid papulosis  
8.2.2. Histopathology in lymphomatoid papulosis  
8.2.3. Staging in lymphomatoid papulosis  
8.2.4. Treatment in Lymphomatoid Papulosis

8.3. Mycosis Fungoides  

8.3.1. Clinic in mycosis fungoides  
8.3.2. Histopathology in mycosis fungoides  
8.3.3. Staging in mycosis fungoides  
8.3.4. Treatment in mycosis fungoides  

8.4. Sezary syndrome  

8.4.1. Clinic in Sezary Syndrome  
8.4.2. Histopathology in Sezary Syndrome 
8.4.3. Staging in Sezary Syndrome  
8.4.4. Treatment in Sezary Syndrome 

8.5. Adult T leukemia  

8.5.1. Clinical features in adult T leukemia  
8.5.2. Histopathology in Adult T Leukemia  
8.5.3. Staging in Adult T Leukemia  
8.5.4. Treatment in Adult T Leukemia  

8.6. Adult T-cell lymphoma  

8.6.1. Clinical features of adult T-cell lymphoma  
8.6.2. Histopathology in Adult T-cell lymphoma  
8.6.3. Staging in Adult T-cell lymphoma  
8.6.4. Treatment features of adult T-cell lymphoma  

8.7. Anaplastic cutaneous large cell anaplastic lymphoma cd30+  

8.7.1. Clinical features in anaplastic cutaneous large cell lymphoma cd30+  
8.7.2. Histopathology in Anaplastic cutaneous large cell anaplastic lymphoma cd30+  
8.7.3. Staging in Anaplastic cutaneous large cell anaplastic lymphoma cd30+  
8.7.4. Treatment features in anaplastic cutaneous large cell lymphoma cd30+  

8.8. Cutaneous primitive B lymphomas  

8.8.1. Clinical features of cutaneous primitive B lymphomas  
8.8.2. Histopathology in cutaneous primitive B-lymphomas  
8.8.3. Staging in Cutaneous primitive B lymphomas  
8.8.4. Treatment features of cutaneous primitive B lymphomas  

8.9. Primary cutaneous lymphomas in childhood  

8.9.1. Clinical features of primary cutaneous lymphomas in childhood
8.9.2. Histopathology in primary cutaneous lymphomas in infancy  
8.9.3. Staging in primary cutaneous lymphomas in childhood  
8.9.4. Treatment in primary cutaneous lymphomas in childhood  

8.10. Follow-up and recommendations  

8.10.1. Initial stage: First year  
8.10.2. Follow up: Second year  
8.10.3. In the Long Term  
8.10.4. Recommendations 

Module 9. Genodermatoses Predisposing to Skin Cancer

9.1. Neurofibromatosis

9.1.1. Analysis of Neurofibromatosis  
9.1.2. Clinical features of neurofibromatosis  
9.1.3. Histopathology features of neurofibromatosis  
9.1.4. Treatment in neurofibromatosis  

9.2. Tuberous Sclerosis  

9.2.1. Tuberous Sclerosis Evaluation  
9.2.2. Clinical manifestations of Tuberous Sclerosis  
9.2.3. Histopathology manifestations of Tuberous Sclerosis  
9.2.4. Treatment in tuberous sclerosis  

9.3. Elastic Pseudoxanthoma   

9.3.1. Analysis of the elastic pseudoxanthoma  
9.3.2. Clinical features in elastic Pseudoxanthoma   
9.3.3. Histopathology features in elastic Pseudoxanthoma  
9.3.4. Treatment in elastic  pseudoxanthoma   

9.4. Ehlers-Danlos Syndrome  

9.4.1. Evaluation of Ehlers-Danols syndrome
9.4.2. Clinical features of Ehlers-Danols syndrome  
9.4.3. Histopathology in Ehlers-Danols syndrome  
9.4.4. Treatment in Ehlers-Danols syndrome  

9.5. Muir-Torre syndrome  

9.5.1. Analysis of the Muir-Torre Syndrome  
9.5.2. Muir-Torre Syndrome Clinic  
9.5.3. Histopathology in Muir-Torre Syndrome  
9.5.4. Treatment in Muir-Torre Syndrome  

9.6. Gorlin or nevoid basal cell carcinoma syndrome  

9.6.1. Evaluation of Gorlin's syndrome or nevoid basal cell carcinoma  
9.6.2. Clinical features of Gorlin's syndrome or nevoid basal cell carcinoma  
9.6.3. Histopathology features of Gorlin's syndrome or nevoid basal cell carcinoma  
9.6.4. Treatment in Gorlin's Syndrome or nevoid basal cell carcinoma

9.7. Cowden's syndrome (multiple hamartomas)  

9.7.1. Analysis of Cowden syndrome (multiple Hamartomas)
9.7.2. Clinic in Cowden syndrome (multiple Hamartomas)
9.7.3. Histopathology in Cowden's syndrome (multiple Hamartomas)  
9.7.4. Treatment in Cowden's syndrome (multiple Hamartomas)  

9.8. Gardner syndrome  

9.8.1. Evaluation of Gardner's Syndrome  
9.8.2. Clinical features of Gardner's syndrome  
9.8.3. Histopathology in Gardner's Syndrome  
9.8.4. Treatment in Gardner syndrome  

9.9. Pigmentovascular phakomatosis associated with hypochromic nevus   

9.9.1. Evaluation of pigmentovascular phakomatosis associated with hypochromic nevus
9.9.2. Clinical features of Pigmentovascular phakomatosis associated with hypochromic nevus  
9.9.3. Histopathology features of Pigmentovascular phakomatosis associated with hypochromic nevus  
9.9.4. Treatment features of Pigmentovascular phakomatosis associated with hypochromic nevus  

9.10. Congenital pachyonychia in multiple family members

9.10.1. Analysis of Pachyonychia congenita  
9.10.2. Clinical features of pachyonychia congenita  
9.10.3. Histopathology in Pachyonychia congenita  
9.10.4. Treatment in Pachyonychia congenita 

Module 10. Dermatologic Pathology in the Oncology Patient   

10.1. Evaluation of dermatologic pathology in the oncology patient  

10.1.1. Pathology analysis  
10.1.2. Evolution of the pathology  
10.1.3. Epidemiology of the pathology  
10.1.4. Etiopathogenesis of the pathology  

10.2. Diagnosis  

10.2.1. Clinical Symptoms  
10.2.2. Histology  
10.2.3. Immunohistochemistry
10.2.4. Diagnosis 

10.3. Skin lesions induced by conventional antineoplastic QT  

10.3.1. Erythema toxicum of QT  
10.3.2. Localized Epidermal Necrolysis  
10.3.3. Epidermal cytotoxicity syndrome Acral erythema/ Foot-hand syndrome  
10.3.4. Reactivation ("recall") reactions

10.4. Paraneoplastic dermatomyositis  

10.4.1. Paraneoplastic dermatomyositis analysis  
10.4.2. Paraneoplastic dermatomyositis Clinical Symptoms  
10.4.3. Paraneoplastic dermatomyositis Histopathology  
10.4.4. Paraneoplastic dermatomyositis Treatment  

10.5. Paraneoplastic neutrophilic dermatoses  

10.5.1. Evaluation of paraneoplastic neutrophilic dermatoses  
10.5.2. Clinical signs of paraneoplastic neutrophilic dermatosis  
10.5.3. Histopathology of paraneoplastic neutrophilic dermatoses  
10.5.4. Treatment of paraneoplastic neutrophilic dermatoses  

10.6. Graft-versus-host disease  

10.6.1. Analysis of graft-versus-host disease  
10.6.2. Clinical Symptoms of Graft-Versus-Host Disease (GVHD)  
10.6.3. Histopathology of Graft-Versus-Host Disease (GVHD)  
10.6.4. Treatment of graft-versus-host disease  

10.7. Paraneoplastic pemphigus  

10.7.1. Evaluation of paraneoplastic pemphigus  
10.7.2. Clinical manifestations of paraneoplastic pemphigus  
10.7.3. Histopathology of paraneoplastic pemphigus   
10.7.4. Treatment of paraneoplastic pemphigus 

10.8. Skin infections of dermatological interest in oncology patients

10.8.1. Analysis of skin infections  
10.8.2. Clinic of skin infections  
10.8.3. Histopathology of skin infections  
10.8.4. Treatment of skin infections 

10.9. Cutaneous metastases of systemic neoplasms  

10.9.1. Analysis of metastasis of systemic neoplasms  
10.9.2. Clinical Symptoms of metastasis of systemic neoplasms  
10.9.3. Histopathology of metastasis of systemic neoplasms  
10.9.4. Treatment of metastasis of systemic neoplasms  

10.10. Cutaneous Manifestations of Malignant Neoplasms  

10.10.1. Evolution of Cutaneous Manifestations of Malignant Neoplasms  
10.10.2. Clinical Manifestations of Cutaneous Manifestations of Malignant Neoplasms  
10.10.3. Histopathology of Cutaneous Manifestations of Malignant Neoplasms
10.10.4. Treatment of Cutaneous Manifestations of Malignant Neoplasms

You will have at your disposal videos of real case studies and multiple multimedia resources with which you will be able to develop strategies for the differential diagnosis of various pathologies"